Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Cancer therapy developer Orca Bio hopes to turn fresh results from a late-stage clinical trial into regulatory approval next ...

Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

Researchers in China have used the body’s own immune system to kill cancerous cells in a pioneering new therapy.

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Researchers have discovered that cancer cells suppress 'poison exons' -- genetic elements that act as an off switch for protein production -- in a key gene called TRA2 , promoting tumor growth. By ...

Even cells experience peer pressure. Scientists have long studied the ins and outs of cancer cells to learn more about the ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

Researchers uncover how leukemia drains T cells' energy, paving the way for stronger cancer immunotherapy and enhancing CAR T ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...